CGEN
CGEN clinical trials: COMPUGEN LTD
Every trial on ClinicalTrials.gov where COMPUGEN LTD is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 5
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CGEN on the catalyst calendar · CGEN registry changes
- Primary completion Mar 2027Sponsor estimatePhase 1/Phase 2NCT06888921A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian CancerCompugen Ltd · Ovarian CancerActive, not recruitingCGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 22, 2027Sponsor estimatePhase 1NCT06759649A Clinical Trial to Assess COM503 in Participants With Advanced Solid MalignanciesCompugen Ltd · NeoplasmRecruitingCGENLeadGILDCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2026ActualPhase 1NCT04354246COM902 (A TIGIT Inhibitor) in Subjects With Advanced MalignanciesCompugen Ltd · Advanced CancerCompletedCGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 30, 2024ActualPhase 1NCT03667716COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.Compugen Ltd · Advanced CancerCompletedCGENLeadBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 15, 2024ActualPhase 1/Phase 2NCT04570839COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.Compugen Ltd · Endometrial NeoplasmsCompletedCGENLeadBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner